2023
Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression
Jajosky R, Patel K, Allen J, Zerra P, Chonat S, Ayona D, Maier C, Morais D, Wu S, Luckey C, Eisenbarth S, Roback J, Fasano R, Josephson C, Manis J, Chai L, Hendrickson J, Hudson K, Arthur C, Stowell S. Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression. Blood 2023, 142: 1082-1098. PMID: 37363865, PMCID: PMC10541552, DOI: 10.1182/blood.2022018591.Peer-Reviewed Original ResearchConceptsAntibody-mediated immunosuppressionRBC alloantigensImmune responseFetal red blood cell antigensTarget antigenRed blood cell antigensRh immune globulinMaternal immune responseBlood cell antigensInclusion of antibodiesRBC removalAnti-RhD antibodiesAbility of antibodiesImmune globulinAntibody responseHemolytic diseaseRBC clearanceCell antigensFetal RBCsAntibody characteristicsAlloantigensSimilar interventionsAntibodiesAntigenPolyclonal antibody preparationStorage differentially impacts alloimmunization to distinct red cell antigens following transfusion in mice
Maier C, Jajosky R, Patel S, Verkerke H, Fuller M, Allen J, Zerra P, Fasano R, Chonat S, Josephson C, Gibb D, Eisenbarth S, Luckey C, Hudson K, Hendrickson J, Arthur C, Stowell S. Storage differentially impacts alloimmunization to distinct red cell antigens following transfusion in mice. Transfusion 2023, 63: 457-462. PMID: 36708051, PMCID: PMC10414794, DOI: 10.1111/trf.17251.Peer-Reviewed Original ResearchConceptsKEL RBCsAntibody formationAntigen levelsRed blood cell alloimmunizationIgG antibody productionDifferent clinical outcomesIgG antibody formationRed cell antigensAlloantibody productionRBC alloimmunizationClinical outcomesTransfusionAlloimmunizationRBC clearanceCell antigensClinical experienceSpecific antigenAntibody productionRBC antigensRBC survivalAntibody developmentModel antigenAntigenAdditional studiesFresh RBCsThe impact of ABO and RhD blood types on Babesia microti infection
Jajosky R, O’Bryan J, Spichler-Moffarah A, Jajosky P, Krause P, Tonnetti L. The impact of ABO and RhD blood types on Babesia microti infection. PLOS Neglected Tropical Diseases 2023, 17: e0011060. PMID: 36696414, PMCID: PMC9901808, DOI: 10.1371/journal.pntd.0011060.Peer-Reviewed Original ResearchConceptsB. microti infectionABO blood typeBabesia microti infectionMicroti infectionBlood donorsBlood typeDisease severityPlasmodium falciparum malaria patientsFalciparum malaria patientsHigher peak parasitemiaRed blood cell antigensType BImpact of ABOBlood cell antigensBlood type BMalaria patientsTransfusion strategyInfected donorsRhD blood typeSevere diseasePeak parasitemiaB antigensCell antigensPossible associationRhD antigen
2010
Hemolytic Disease of the Newborn
Shamsi T, Hossain N, Paidas M. Hemolytic Disease of the Newborn. 2010, 28-40. DOI: 10.1002/9781444328332.ch3.Peer-Reviewed Original ResearchHemolytic diseaseRed cell antigensCell antigensMiddle cerebral artery peak systolic velocityFetal middle cerebral artery peak systolic velocityAppropriate blood productsFetus/neonatePeak systolic velocityMaternal red cellsRed cellsRed cell sensitizationRed cell destructionClasses of antibodiesRhesus blood groupsIntrauterine transfusionAntenatal managementTerm neonatesFetal anemiaPaternal antigensSubsequent pregnancyFirst pregnancyNegative pregnancyAntenatal prophylaxisDoppler interrogationProphylaxis program
2002
Cytokines and Human Type 1 Diabetes
Kent S, Viglietta V, Hafler D. Cytokines and Human Type 1 Diabetes. 2002, 295-316. DOI: 10.1007/978-1-59259-129-9_12.Peer-Reviewed Original ResearchHuman leukocyte antigenGlutamic acid decarboxylaseType 1 diabetesContribution of human leukocyte antigenHuman type 1 diabetesPresence of autoantibodiesIslet cell antigensGenetic associationCytokine-mediated eventsLeukocyte antigenDisease developmentHLA-DQ8Cell antigensMouse modelDisease onsetAcid decarboxylaseDiagnostic useMetabolic measuresAntigenWell-characterizedDiseaseAutoantibodiesRisk
1995
REACTIVITY OF WHITE-FOOTED MOUSE AND RACCOON SERA TO WHOLE CELL AND RECOMBINANT ANTIGENS OF BORRELIA BURGDORFERI
Magnarelli L, Anderson J, Flavell R, Fikrig E. REACTIVITY OF WHITE-FOOTED MOUSE AND RACCOON SERA TO WHOLE CELL AND RECOMBINANT ANTIGENS OF BORRELIA BURGDORFERI. Journal Of Wildlife Diseases 1995, 31: 339-44. PMID: 8592354, DOI: 10.7589/0090-3558-31.3.339.Peer-Reviewed Original ResearchConceptsWhole cell antigenCell antigensRecombinant antigensSpecific recombinant antigensGeometric mean antibody titersMean antibody titersPresence of antibodiesB. burgdorferi infectionEnzyme-linked immunosorbentWhite-footed miceAntibody titersBorrelia burgdorferi sensu strictoBurgdorferi infectionBurgdorferi sensu stricto
1991
Identification of a novel high molecular weight protein preferentially expressed by sinusoidal endothelial cells in normal human tissues.
Goerdt S, Walsh LJ, Murphy GF, Pober JS. Identification of a novel high molecular weight protein preferentially expressed by sinusoidal endothelial cells in normal human tissues. Journal Of Cell Biology 1991, 113: 1425-1437. PMID: 2045420, PMCID: PMC2289031, DOI: 10.1083/jcb.113.6.1425.Peer-Reviewed Original ResearchConceptsSinusoidal endothelial cellsEndothelial cellsPeripheral blood mononuclear cellsMS-1 antigenDendritic cell populationsEndothelial cell antigensBlood mononuclear cellsHigh endothelial venulesHuman umbilical vein endothelial cellsUmbilical vein endothelial cellsVein endothelial cellsLymph nodesKG-1 cellsNormal human tissuesMononuclear cellsLymphoid tissueAdrenal cortexEndothelial venulesCell line KG-1Cell line U937Cell antigensSplenic tissueSinusoidal endotheliumSplenic extractSpleen
1988
LYTIC ANTI-ENDOTHELIAL CELL ANTIBODIES IN HAEMOLYTIC-URAEMIC SYNDROME
Leung D, Havens P, Moake J, Kim M, Pober J. LYTIC ANTI-ENDOTHELIAL CELL ANTIBODIES IN HAEMOLYTIC-URAEMIC SYNDROME. The Lancet 1988, 332: 183-186. PMID: 2899661, DOI: 10.1016/s0140-6736(88)92287-8.Peer-Reviewed Original ResearchConceptsAnti-endothelial cell antibodiesHaemolytic uraemic syndromeThrombotic thrombocytopenic purpuraCell antibodiesComplement-fixing IgGDisorder of immunoregulationAnti-endothelial antibodiesEndothelial cell antigensCultured human umbilical vein endothelial cellsGamma-interferon treatmentHuman umbilical vein endothelial cellsUmbilical vein endothelial cellsAdult patientsVein endothelial cellsThrombocytopenic purpuraIgM antibodiesVascular injuryInterferon treatmentUraemic syndromeGamma interferonCell antigensControl seraEndothelial cellsAntibodiesSerum
1985
Phenotype of recovering lymphoid cell populations after marrow transplantation.
Ault KA, Antin JH, Ginsburg D, Orkin SH, Rappeport JM, Keohan ML, Martin P, Smith BR. Phenotype of recovering lymphoid cell populations after marrow transplantation. Journal Of Experimental Medicine 1985, 161: 1483-1502. PMID: 3159819, PMCID: PMC2187630, DOI: 10.1084/jem.161.6.1483.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply